Medical Marijuana: Dr. Kogan's Evidence-Based Guide to the Health Benefits of Cannabis and CBD, is an essential guide to understanding the health benefits of marijuana and CBD.
Marijuana has been used for thousands of years as a medicine, but pot has been illegal in the United States for most of our lives. Almost all states have now legalized its medical use, and many consumers and physicians are exploring it as an alternative to conventional treatments. There’s substantial evidence that marijuana (cannabis) is a safe and effective treatment for chronic pain, chemo side effects, sleep and mood disorders, MS, and Parkinson’s disease, among others. But there’s also misinformation about marijuana on social media. And most physicians have limited knowledge on the subject, while dispensary staff (aka “budtenders”) lack medical training.
Mikhail Kogan, MD, a renowned expert on medical marijuana, has found that cannabinoids (THC, CBD, hemp, and other cannabis products) can often be more beneficial, have fewer side effects, and be safer than many conventional medications, including opioids and other painkillers. But different ailments require different strains, doses, and routes of delivery. Medical Marijuana demystifies marijuana and other forms of cannabis in a user-friendly guide that will help readers:
• Understand how marijuana morphed from the days of “Reefer Madness” to being hailed as a wonder weed
• Navigate the complex medical and legal world of marijuana
• Understand the risks and benefits of THC, CBD, and other cannabis products
• Evaluate the pros and cons of inhaled and other routes of delivery: edibles, topicals, and even suppositories
• Find a doctor who can recommend medical cannabis
• Choose a reliable dispensary
• Learn how to evaluate labels on cannabis products
• Discover cost-saving strategies since medical marijuana isn’t covered by health insurance
With real-life patients’ stories woven throughout the book, simple explanatory graphics, and the most up-to-date information, this is the definitive guide to the wide-ranging benefits of medical marijuana and other forms of cannabis.
"It's a must read not only for consumers who are contemplating using medical marijuana for the first time, but also for those who are currently using it and want to expand their knowledge. And, given the gap in knowledge amount medical professionals - and the fact that millions of Americans are now using medical marijuana - I highly recommend that doctors, too, read Medical Marijuana, not just for their education but for their patients' benefit as well." - Andrew Weil, MD
Dr. Mark Hyman recently spoke with Dr. Kogan on his podcast Advances In Therapeutic Uses of Medical Marijuana regarding the new book. Listen below:
Montel Williams also spoke with Dr. Kogan regarding his new book on his podcast Let's Be Blunt. Listen and watch below:
Mikhail Kogan, MD, ABOIM is a leader in the newly established field of Integrative Geriatrics. He is board-certified in Internal Medicine, Geriatrics, Palliative Care, and Integrative Medicine, is the editor of “Integrative Geriatric Medicine” Oxford University Press textbook, and is a frequent speaker on the topics of Integrative Medicine and Geriatrics, healthy aging, neurodegenerative diseases, and use of medical cannabis. Dr. Kogan currently serves as medical director of the GW Center for Integrative Medicine, is the founder and director of the George Washington University Integrative Geriatrics Fellowship Track and the director of the Integrative Medicine Track program at the George Washington University School of Medicine. He also serves as a part-time faculty member of the George Washington Institute for Spirituality and Health and the GW Center for Aging, Health and Humanities. Dr. Kogan has been early adopter of the Washington, D.C. Medical Cannabis program and has been instrumental in the D.C. Rx Medical Cannabis education program. He is also the chair of the board of AIM Health Institute, a Washington, D.C based non-profit organization providing integrative medicine services to low-income and terminally ill patients regardless of their ability to pay.